Double-Blind, Randomized Trial of Long-Chain Polyunsaturated Fatty Acid Supplementation in Formula Fed to Preterm Infants
* MRC Childhood Nutrition Research Center, Institute of Child Health, London, United Kingdom
Department of Paediatrics, University of Melbourne, and Murdoch Children’s Research Institute, Melbourne, Australia
School of Human Movement Studies, Queensland Institute of Technology, Brisbane, Australia
|| Academic Division of Child Health, University Hospital, Nottingham, United Kingdom
¶ Pediatric Department, Stirling Royal Infirmary NHS Trust, Stirling, United Kingdom
Objective. We tested the hypothesis that balanced addition of long-chain polyunsaturated fatty acid (LCPUFA) to preterm formula during the first weeks of life would confer long-term neurodevelopmental advantage in a double-blind, randomized, controlled trial of preterm formula with and without preformed LCPUFA.
Methods. The participants were 195 formula-fed preterm infants (birth weight <1750 g, gestation <37 weeks) from 2 UK neonatal units and 88 breast milk-fed infants. Main outcome measures were Bayley Mental Developmental Index (MDI) and Psychomotor Developmental Index (PDI) at 18 months and Knobloch, Passamanick and Sherrard’s Developmental Screening Inventory at 9 months’ corrected age. Safety outcome measures were anthropometry at 9 and 18 months, tolerance, infection, necrotizing enterocolitis, and death.
Results. There were no significant differences in developmental scores between randomized groups, although infants who were fed LCPUFA-supplemented formula showed a nonsignificant 2.6-point (0.25 standard deviation) advantage in MDI and PDI at 18 months, with a greater (nonsignificant) advantage (MDI: 4.5 points; PDI: 5.8 points) in infants below 30 weeks’ gestation. LCPUFA-supplemented infants were shorter than control infants at 18 months (difference in length standard deviation score: 0.44; 95% confidence interval: 0.08–0.8). No other significant short- or long-term differences in safety outcomes were observed. Breastfed infants had significantly higher developmental scores at 9 and 18 months than both formula groups and were significantly heavier and longer at 18 months than LCPUFA-supplemented but not control infants.
Conclusions. With the dose, duration, and preparation of LCPUFA used, efficacy was not demonstrated, although an advantage in later neurodevelopment cannot be excluded by global tests of development up to 18 months, particularly in infants below 30 weeks’ gestation. The surprising effect of LCPUFA-supplemented formula on growth 18 months beyond the intervention period needs to be confirmed in other studies using similar supplementation strategies. Additional follow-up of this cohort is critical at an age when more specific tests of cognitive function are possible.
Key Words: LCPUFA • preterm infant • randomized trial • efficacy • safety • neurodevelopment • growth
Abbreviations: LCPUFA, long-chain polyunsaturated fatty acids • AA, arachidonic acid • DHA, docosahexanoic acid • HC, head circumference • MDI, Mental Developmental Index • PDI, Psychomotor Developmental Index • SD, standard deviation • NEC, necrotizing enterocolitis • CI, confidence interval
Received for publication Jun 5, 2001; Accepted Dec 18, 2001.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Makrides, R. A. Gibson, A. J. McPhee, C. T. Collins, P. G. Davis, L. W. Doyle, K. Simmer, P. B. Colditz, S. Morris, L. G. Smithers, et al. Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid: A Randomized Controlled Trial JAMA, January 14, 2009; 301(2): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G Smithers, R. A Gibson, A. McPhee, and M. Makrides Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1049 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Drenckpohl, C. McConnell, S. Gaffney, M. Niehaus, and K. S. Macwan Randomized Trial of Very Low Birth Weight Infants Receiving Higher Rates of Infusion of Intravenous Fat Emulsions During the First Week of Life Pediatrics, October 1, 2008; 122(4): 743 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S Fewtrell, K. Kennedy, A. Singhal, R. M Martin, A. Ness, M. Hadders-Algra, B. Koletzko, and A. Lucas How much loss to follow-up is acceptable in long-term randomised trials and prospective studies? Arch. Dis. Child., June 1, 2008; 93(6): 458 - 461. [Full Text] [PDF]
|
|
|
|
|
|
C. Henriksen, K. Haugholt, M. Lindgren, A. K. Aurvag, A. Ronnestad, M. Gronn, R. Solberg, A. Moen, B. Nakstad, R. K. Berge, et al. Improved Cognitive Development Among Preterm Infants Attributable to Early Supplementation of Human Milk With Docosahexaenoic Acid and Arachidonic Acid Pediatrics, June 1, 2008; 121(6): 1137 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G Smithers, R. A Gibson, A. McPhee, and M. Makrides Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials Am. J. Clinical Nutrition, April 1, 2008; 87(4): 912 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Smithers, R. A. Gibson, and M. Makrides Long-chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation for Infants Born Preterm NeoReviews, April 1, 2007; 8(4): e143 - e151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S M Montgomery, A Ehlin, and A Sacker Breast feeding and resilience against psychosocial stress Arch. Dis. Child., December 1, 2006; 91(12): 990 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sacker, M. A. Quigley, and Y. J. Kelly Breastfeeding and Developmental Delay: Findings From the Millennium Cohort Study Pediatrics, September 1, 2006; 118(3): e682 - e689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Wright-Rodgers, M. K. Waldron, K. E. Bigley, G. E. Lees, and J. E. Bauer Dietary Fatty Acids Alter Plasma Lipids and Lipoprotein Distributions in Dogs during Gestation, Lactation, and the Perinatal Period J. Nutr., September 1, 2005; 135(9): 2230 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C McCann and B. N Ames Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Makrides, R. A Gibson, T. Udell, K. Ried, and the International LCPUFA Investigators Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1094 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Wright, J. E. Bauer, K. E. Bigley, G. E. Lees, and M. K. Waldron Maternal Dietary Fatty Acids Modify Canine Puppy Plasma Lipoprotein Distributions during the Suckling Period J. Nutr., August 1, 2004; 134(8): 2106S - 2109S. [Full Text] [PDF]
|
|
|
|
|
|
M. T. Clandinin, J. VanAerde, M. Fewtrell, and A. Lucas Formula Supplementation and Growth Pediatrics, December 1, 2003; 112(6): 1456 - 1458. [Full Text] [PDF]
|
|
|
|
|
|
N. Auestad, D. T. Scott, J. S. Janowsky, C. Jacobsen, R. E. Carroll, M. B. Montalto, R. Halter, W. Qiu, J. R. Jacobs, W. E. Connor, et al. Visual, Cognitive, and Language Assessments at 39 Months: A Follow-up Study of Children Fed Formulas Containing Long-Chain Polyunsaturated Fatty Acids to 1 Year of Age Pediatrics, September 1, 2003; 112(3): e177 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. K. Koo Efficacy and Safety of Docosahexaenoic Acid and Arachidonic Acid Addition to Infant Formulas: Can One Buy Better Vision and Intelligence? J. Am. Coll. Nutr., April 1, 2003; 22(2): 101 - 107. [Abstract] [Full Text]
|
|
